Category Development

Johnson & Johnson Denies Patent Pool Licences For HIV Medicines For The Poor

In a move public health advocates say is likely to bring negative consequences for low-income patients with HIV and AIDS, as well as negative publicity for the company, Johnson & Johnson recently announced that it would not enter into negotiations with the Medicines Patent Pool for voluntary licences that would allow several of key treatments to be made in more affordable generic form in developing countries.

Book: Shape Up International Reforms To Address Food Security

Current global institutional reforms of agricultural innovation systems and the commodification of crop diversity are not answering concerns regarding international equity in access to plant genetic resources, the handling of agricultural research, and the sharing of benefits arising from this research, according to a new book by Claudio Chiarolla, research fellow at the Paris-based Institut du développement durable et des relations internationales (IDDRI).

Most-Read IP-Watch Posts Of 2011 Tell Story Of International IP Policymaking

The most-read Intellectual Property Watch stories of 2011 demonstrated the versatility and range of our readers from around the globe, from an intense focus on international and national copyright issues to bilateral and plurilateral free trade agreements, to issues in India and Brazil, patent laws, patents in agriculture, scientific knowledge, and of course, policies emerging in Geneva at the World Intellectual Property Organization, World Trade Organization, World Health Organization and elsewhere at the multilateral level. Most of all, they tell the story of the year gone by, with clear signals of what's to come in 2012.

WIPO Patent Law Committee Sets Sights On “Balance” Among Member Interests

The World Intellectual Property Organization patent law committee this week is discussing a range of issues with a UN-style sensitivity to all levels of development and patent ownership. Issues on the agenda range from patent quality, public health, exceptions and limitations, client-attorney confidentiality, and technology transfer.